Aseptic Processing Practices and Process Validation of ...

CBE 107 V1 Aseptic Processing Practices and Process Validation of Aseptic Operators CBE Pty Ltd This training program is copyright to CBE Pty Ltd and may not be modified, reproduced, sold, loaned, hired or traded in any form without its express written permission. 1 Introduction CBE 107 V1 2 Module Outcomes On completion of this module the participant should be able to: Relate relative risks between terminal sterilisation and Aseptic Processing Interpret the requirements of the FDA and PICs guides to Aseptic Processing . Define the importance of media fills/ Process simulations to sterility assurance State the Validation requirements and acceptance criteria for Aseptic media fills Identify worst case conditions and critical interventions Introduction CBE 107 V1 Module Topics Describe risks associated with Aseptic Processing sterile Processing GMP Expectations Identify related support systems Outline a worst case media fill for Aseptic Processing Validation Introduction CBE 107 V1 Important References PIC/S Guide to Good Manufacturing Practice for Medicinal Products Annex 1 Manufacture of sterile Medicinal Products PIC/S Recommendation on the Validation of Aseptic Processes January 2011 FDA Guideline on sterile Drug Products Produced by Aseptic Processing Sept 2004 PDA - Points to Consider for Aseptic Processing ISO 13408-1:2008

Different container – closure combinations Maximum # personnel in the room Changeovers and sterile hold times for equipment 100% inspection process Run size: 5000 or maximum # processed on lien for the container closure combination. Pass = NIL positives Media Fills 19

Loading..

Tags:

  Sterile, Closures, Container, Container closure

Information

Related search queries